Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding
Información
- DOI:
- https://doi.org/10.1002/14651858.CD005415.pub2Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 18 octubre 2006see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Review
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Salud digestiva
- Copyright:
-
- Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
All review authors were responsible for conception of the review and protocol design. AS and SD performed eligibility checks on the search results, data extraction and contributed to the writing up of the initial version of the review. SD did not take any further part in this update. AS and JM performed eligibility checks on the search results. AS and JM carried out the data extraction. Statistical analyses were performed by AS. The manuscript was updated by AS, GL and JM; all review authors provided critical review. All review authors contributed to final editing of the review and gave final approval.
Sources of support
Internal sources
-
University of Leeds, UK.
External sources
-
NHS R & D Health Technology Assessment Programme (Project 03/12/03), UK.
Declarations of interest
A Sreedharan ‐ Has received speaker fees from Astra Zeneca and has accepted honoraria from Abbott for attending scientific meetings
Janet Martin ‐ co‐investigator in a partner grant between industry (Astra Zeneca) and CIHR, but does not receive any payment from this grant.
G Leontiadis ‐ Has received speaker fees and reimbursement for expenses to attend scientific meetings from AstraZeneca, Sanofi‐Aventis, Janssen‐Cilag and GlaxoSmithKline.
D Forman ‐ Has received speaker fees from Astra Zeneca
P Moayyedi ‐ Chair is partly funded by an unrestricted donation from AstraZeneca to McMaster University.
Has been on the speaker's bureau for AstraZeneca, Altana and Janssen‐Ortho
Has been on the advisory boards of AstraZeneca and Janssen‐Ortho
C Howden ‐ Previously consulted for TAP Pharmaceutical Products Inc, Takeda Chemical Industries, and Altana Pharma
Currently consults for Santarus Inc., Takeda Pharmaceuticals North America, Procter & Gamble, Xenoport
Speaker's bureau for Santarus Inc, AstraZeneca and Takeda Pharmaceuticals North America
Previous research grant support from AstraZeneca
Was previously an investigator and speaker for Merck.
Acknowledgements
Iris Gordon, Trial Search Coordinator for Cochrane Upper Gastrointestinal and Pancreatic Disease group, for conducting the initial literature searches.
We acknowledge Racquel Simpson, Trial Search Coordinator for Cochrane Upper Gastrointestinal and Pancreatic Disease group for conducting the updated literature searches in October 2008.
We thank Jan Lilleyman and Cathy Bennett for coordinating the update of this review and for administrative and logistical support.
Version history
| Published | Title | Stage | Authors | Version |
| 2022 Jan 07 | Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding | Review | Takeshi Kanno, Yuhong Yuan, Frances Tse, Colin W Howden, Paul Moayyedi, Grigorios I Leontiadis | |
| 2010 Jul 07 | Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding | Review | Aravamuthan Sreedharan, Janet Martin, Grigorios I Leontiadis, Stephanie Dorward, Colin W Howden, David Forman, Paul Moayyedi | |
| 2006 Oct 18 | Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding | Review | Aravamuthan Sreedharan, Janet Martin, Grigorios I Leontiadis, Stephanie Dorward, Colin W Howden, David Forman, Paul Moayyedi | |
| 2005 Jul 20 | Proton Pump Inhibitors (before endoscopic diagnosis) in upper gastrointestinal bleeding | Protocol | Stephanie Dorward, David Forman, Colin W Howden, Grigoris I Leontiadis, Aravamuthan Sreedharan | |
Differences between protocol and review
A post hoc decision was made to include a third author to independently data extract. Two post hoc analyses were conducted; concerning blood transfusion requirements and proportion of participants with presence of blood in the stomach.
Notes
Protocol Published as 'Proton Pump Inhibitors (before endoscopic diagnosis) in upper gastrointestinal bleeding'. Dorward S, Forman D, Howden CW, Leontiadis GI, Sreedharan A The Cochrane Database of Systematic Reviews Published in Issue 2, 2006. Copyright © 2005 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
